Business Description
Encompass Health Corp
NAICS : 621498
SIC : 8093
ISIN : US29261A1007
Total Employee Number:
29,944Compare
Compare
Traded in other countries / regions
EHC.USAHSOA.GermanyEHC.Mexico IPO Date
2019-03-06Description
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals, which is the company's sole segment. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. The company's inpatient rehabilitation hospitals provide a higher level of rehabilitative care to patients who are recovering from conditions such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.35 | |||||
Debt-to-Equity | 1.11 | |||||
Debt-to-EBITDA | 1.91 | |||||
Interest Coverage | 8.83 | |||||
Piotroski F-Score | 9/9 | |||||
Altman Z-Score | 3.25 | |||||
Beneish M-Score | -2.81 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.3 | |||||
3-Year EBITDA Growth Rate | 16.6 | |||||
3-Year EPS without NRI Growth Rate | 24.1 | |||||
3-Year FCF Growth Rate | 52.5 | |||||
3-Year Book Growth Rate | 22.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 10 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 8.2 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.17 | |||||
Quick Ratio | 1.17 | |||||
Cash Ratio | 0.13 | |||||
Days Sales Outstanding | 37.81 | |||||
Days Payable | 243.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Dividend Growth Rate | -5.8 | |||||
3-Year Average Share Buyback Ratio | -0.1 | |||||
Shareholder Yield % | 3.33 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 95.77 | |||||
Operating Margin % | 17.93 | |||||
Net Margin % | 10.04 | |||||
EBITDA Margin % | 24.11 | |||||
FCF Margin % | 7.64 | |||||
OCF Margin % | 19.76 | |||||
ROE % | 25.87 | |||||
ROA % | 8.78 | |||||
ROIC % | 13.92 | |||||
3-Year ROIIC % | 27.47 | |||||
ROC (Joel Greenblatt) % | 26.31 | |||||
ROCE % | 18.46 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 9 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 17.77 | |||||
Forward PE Ratio | 12.21 | |||||
PE Ratio without NRI | 18.71 | |||||
Shiller PE Ratio | 25.05 | |||||
Price-to-Owner-Earnings | 26.36 | |||||
PEG Ratio | 1.52 | |||||
PS Ratio | 1.79 | |||||
PB Ratio | 4.2 | |||||
Price-to-Tangible-Book | 11.71 | |||||
Price-to-Free-Cash-Flow | 23.3 | |||||
Price-to-Operating-Cash-Flow | 9.03 | |||||
EV-to-EBIT | 12.97 | |||||
EV-to-Forward-EBIT | 14.16 | |||||
EV-to-EBITDA | 9.98 | |||||
EV-to-Forward-EBITDA | 10.28 | |||||
EV-to-Revenue | 2.41 | |||||
EV-to-Forward-Revenue | 1.97 | |||||
EV-to-FCF | 30.33 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 1.7 | |||||
Price-to-DCF (Earnings Based) | 0.99 | |||||
Price-to-DCF (FCF Based) | 1.33 | |||||
Price-to-Median-PS-Value | 1.32 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.66 | |||||
Price-to-Graham-Number | 3.12 | |||||
Earnings Yield (Greenblatt) % | 7.71 | |||||
FCF Yield % | 4.19 | |||||
Forward Rate of Return (Yacktman) % | 13.92 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Encompass Health Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil MXN) | 111,134.506 | ||
| EPS (TTM) (MXN) | 109.489 | ||
| Beta | 0.0014 | ||
| 3-Year Sharpe Ratio | -65.65 | ||
| 3-Year Sortino Ratio | -3.46 | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (MXN) | - | ||
| 20-Day SMA (MXN) | 1280.07517 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (MXN) | 1280.07517 - 1280.07517 | ||
| Shares Outstanding (Mil) | 99.2 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Encompass Health Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Encompass Health Corp Stock Events
| Event | Date | Price (MXN) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-10-30 10:00 | In 120 days | ||
| Third quarter earnings results for 2026 | 2026-10-29 | In 118 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-05 10:00 | In 34 days | ||
| Second quarter earnings results for 2026 | 2026-08-04 | In 32 days | ||
| USD 0.190000 Cash Dividend | 2026-07-01 | 1,280.08 (+0.00%) | ||
| Guidance call for 2026 | 2026-05-12 08:40 | 1,280.08 (+0.00%) | ||
| General meeting for 2026 | 2026-05-07 11:00 | 1,280.08 (+0.00%) | ||
| First quarter earnings conference call for 2026 | 2026-05-01 10:00 | 1,280.08 (+0.00%) | ||
| First quarter earnings results for 2026 | 2026-04-30 | 1,280.08 (+0.00%) | ||
| Barclays Global Healthcare Conference | 2026-03-11 09:00 | 1,280.08 (+0.00%) |
Show
Entries
Encompass Health Corp Frequently Asked Questions
What is Encompass Health Corp(MEX:EHC)'s stock price today?
The current price of MEX:EHC is MXN1280.08. The 52 week high of MEX:EHC is MXN1280.08 and 52 week low is MXN1280.08.
When is next earnings date of Encompass Health Corp(MEX:EHC)?
The next earnings date of Encompass Health Corp(MEX:EHC) is 2026-08-04 Est..
Does Encompass Health Corp(MEX:EHC) pay dividends? If so, how much?
Encompass Health Corp(MEX:EHC) does not pay dividend.
Press Release
Articles on Encompass Health Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers